rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-9-27
|
pubmed:abstractText |
Prostanoids are a well-established therapy for pulmonary arterial hypertension (PAH), and observational studies suggest their efficacy even in chronic thromboembolic pulmonary hypertension (CTEPH) patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0008-6312
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2006 S. Karger AG, Basel.
|
pubmed:issnType |
Print
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
168-73
|
pubmed:meshHeading |
pubmed-meshheading:16645271-Adult,
pubmed-meshheading:16645271-Case-Control Studies,
pubmed-meshheading:16645271-Chronic Disease,
pubmed-meshheading:16645271-Epoprostenol,
pubmed-meshheading:16645271-Exercise Test,
pubmed-meshheading:16645271-Female,
pubmed-meshheading:16645271-Humans,
pubmed-meshheading:16645271-Hypertension, Pulmonary,
pubmed-meshheading:16645271-Male,
pubmed-meshheading:16645271-Middle Aged,
pubmed-meshheading:16645271-Thromboembolism,
pubmed-meshheading:16645271-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study.
|
pubmed:affiliation |
Department of Cardiovascular and Respiratory Sciences, University La Sapienza, Rome, Italy. dario.vizza@uniroma1.it
|
pubmed:publicationType |
Journal Article
|